Atreca Inc
Biotechnology
Healthcare
BCEL
38.72 M shares
NASDAQ US
traded
16 Mar 2023
listed
yes
open
1.40
52 week high
5.20
high
1.42
52 week low
1.33
previous Close
1.33
P/E ratio
market cap
61.73 M
div yield
0
net incoming
-23.06 M
17.28 %
net profit margin
-2305900000.00 %
0.00 %
operating incoming
-23.29 M
0.00 %
net change in cash
-5.89 M
73.40 %
cash on hand
20.90 M
-20.96 %
top